Plasma carcinoembryonic antigen in renal cell carcinoma patients.
D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000601:surgery; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000276:immunology / Q000473:pathology; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D003510:Cyclohexanes / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000601:surgery; D008113:Liver Neoplasms / Q000276:immunology / Q000473:pathology; D008175:Lung Neoplasms / Q000276:immunology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000276:immunology; D009392:Nephrectomy; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011863:Radioimmunoassay; D013125:Spinal Neoplasms / Q000097:blood / Q000276:immunology / Q000473:pathology
D002272:Carcinoembryonic Antigen; D003510:Cyclohexanes; D009607:Nitrosourea Compounds